Robert Jeremy Rothrock, MD

Samer D. Tabbal, M.D., is a board-certified neurologist and director of the movement disorders program at Baptist Health Miami Neuroscience Institute. He specializes in Parkinson’s disease and other movement disorders, botulinum toxin (Botox) injections and deep brain stimulation programming for Parkinson’s disease, tremor and dystonia. Prior to joining Baptist Health, Dr. Tabbal was the professor of neurology and attending neurologist at Penn State College of Medicine, in Hershey, Penn. During his career, he held the position of director of the Deep Brain Stimulation Program for Parkinson’s Disease and Other Movement Disorders at Washington University in St. Louis for 10 years and developed a movement disorder center at his alma mater, the American University of Beirut in Lebanon. Dr. Tabbal earned his medical degree at American University of Beirut. He completed his neurology residency at the University of Arkansas for Medical Sciences in Little Rock and a two-year fellowship in movement disorders at Columbia University, College of Physicians & Surgeons in New York City. Widely published in peer-reviewed publications, Dr. Tabbal’s research focuses on the mechanisms of action of deep brain stimulation and its effects on brain imaging, movement control, cognition and mood. Dr. Tabbal is certified by the American Board of Psychiatry & Neurology. He is a fellow of the American Academy of Neurology and a member of several other professional organizations. Dr. Tabbal’s clinical philosophy is to treat patients as if they were family by providing compassionate, personalized care to enhance their well-being. Dr. Tabbal is fluent in English and Arabic. When he is not researching, educating or treating patients, he enjoys spending time with family as well as hiking, biking, cultural travel, philosophical discussions, watching soccer, scuba diving and exploring marine animals.

Guilherme Dabus, M.D., is the co-director of interventional neuroradiology at Baptist Health Miami Neuroscience Institute. Dr. Dabus specializes in interventional neuroradiology and neuroendovascular surgery. He is fluent in English, Portuguese and Spanish. Prior to joining Miami Neuroscience Institute in 2021, Dr. Dabus served as an attending interventional neuroradiologist at Baptist Health Miami Cardiac & Vascular Institute and interim Chief of Neuroscience at Baptist Health Baptist Hospital from 2019 to 2020. Active in training the next generation of physicians, Dr. Dabus is the director of the Interventional Neuroradiology Fellowship Program at Miami Cardiac & Vascular Institute and Miami Neuroscience Institute. He is also a clinical professor in the Department of Neuroscience at Herbert Wertheim College of Medicine of Florida International University. Dr. Dabus has served as the local principal investigator for several clinical trials and is the national co-PI for the SUMMIT MAX trial. His research has been published more than 120 times in peer-reviewed publications, including Stroke, the Journal of NeuroInterventional Surgery, Neuroradiology, AJNR, Neurosurgery, Journal of Neurosurgery, Handbook of Clinical Neurology and Frontiers in Neurology. He has also authored several chapters for medical textbooks. Dr. Dabus is a leader in his field and serves on the board of directors of the Society of NeuroInterventional Surgery, where he currently holds the position of treasurer. He was the chair of the Society of NeuroInterventional Surgery Annual Meeting held in 2018 in San Francisco. Dr. Dabus serves as a reviewer for numerous publications, including the Journal of NeuroInterventional Surgery, Clinical Neurology and Neurosurgery, Journal of Endovascular Therapy, Stroke, American Journal of Neuroradiology and Interventional Neuroradiology. He is also a sought-after speaker and regularly presents at national and international events. Dr. Dabus’ approach to patient care is to treat all his patients as they were his own family members. When he is not treating patients, Dr. Dabus enjoys spending time with his family, reading, studying music and arts.

Carlos Mauricio Millan, M.D., is a neurologist at Baptist Health Miami Neuroscience Institute specializing in the treatment of epilepsy, including complex cases of pharmacoresistant (drug-resistant) epilepsy. Dr. Millan earned his medical degree at Universidad El Bosque in Bogotá, Colombia. He served as chief resident during his neurology residency at Universidad El Bosque & Fundacion Santa Fe de Bogota in Colombia. He also completed six years of training that included an internal medicine internship, neurology residency and epilepsy fellowship at Jackson Health System, University of Miami Miller School of Medicine. Dr. Millan conducts research in epilepsy and is published in peer-reviewed publications. He is a member of the American Academy of Neurology. To provide the very best care, Dr. Millan takes time to listen to his patients and pay attention to small details. Effective physician-patient communication, he says, results in increased patient trust and greater therapeutic efficacy. Dr. Millan is fluent in English and Spanish. During his free time, he enjoys spending time with his two children and playing tennis.